Chinese Journal of Cancer Research

Vol 36, No 3 (June 2024)

Contents

Guidelines

CSCO guidelines for colorectal cancer version 2024: Updates and discussions

Liubo Chen, Hanguang Hu, Ying Yuan, Shanshan Weng

Consensus and Expert Recommendation

Evidence-based expert consensus on clinical management of safety of Bruton’s tyrosine kinase inhibitors (2024)

Zaiwei Song, Dan Jiang, Lingling Yu, Yixuan Chen, Daobin Zhou, Yue Li, Depei Wu, Lingli Zhang, Liyan Miao, Jun Ma, Jun Zhu, Hongmei Jing, Rongsheng Zhao, on behalf of the Steering Committee, the Consensus Panel and the Evidence Synthesis Group; Evidence-based Pharmacy Professional Committee of Chinese Pharmaceutical Association (CPA), Hospital Pharmacy Professional Committee of Chinese Pharmaceutical Association (CPA), Division of Therapeutic Drug Monitoring of Chinese Pharmacological Society (CPS), Expert Committee on Lymphoma of Chinese Society of Clinical Oncology (CSCO), Expert Committee on Leukemia of Chinese Society of Clinical Oncology (CSCO), Society of Integrative Cardio-Oncology of China Anti-Cancer Association (CACA), Chinese Society of Hematology of Chinese Medical Association (CMA), Hospital Pharmacy Professional Committee of Cross-Straits Medicine Exchange Association (SMEA)

Original Article

Tislelizumab in previously treated, locally advanced unresectable/metastatic microsatellite instability-high/mismatch repair-deficient solid tumors

Jian Li, Ye Xu, Aimin Zang, Yunong Gao, Quanli Gao, Yanqiao Zhang, Dong Wang, Jianming Xu, Ying Yuan, Haiping Jiang, Jieer Ying, Chunmei Shi, Yanhong Deng, Jing Wang, Tianshu Liu, Yi Huang, Xiaoping Qian, Yueyin Pan, Ying Cheng, Sheng Hu, Jin Wang, Mengyue Shi, Ke Wang, Han Hu, Lin Shen

Effectiveness and safety of combined nimotuzumab and S-1 chemotherapy with concurrent radiotherapy for locally advanced esophageal cancer in malnourished and elderly patients: A prospective phase II study

Guojie Feng, Jiao Li, Nuo Yu, Ziyu Zheng, Xiongtao Yang, Lei Deng, Tao Zhang, Wenqing Wang, Wenyang Liu, Jianyang Wang, Qinfu Feng, Jima Lyu, Zefen Xiao, Zongmei Zhou, Nan Bi, Jianjun Qin, Xin Wang

Clinical and molecular significance of homologous recombination deficiency positive non-small cell lung cancer in Chinese population: An integrated genomic and transcriptional analysis

Yifei Wang, Yidan Ma, Lei He, Jun Du, Xiaoguang Li, Peng Jiao, Xiaonan Wu, Xiaomao Xu, Wei Zhou, Li Yang, Jing Di, Changbin Zhu, Liming Xu, Tianlin Sun, Lin Li, Dongge Liu, Zheng Wang

Nucleotide excision repair gene polymorphisms and hepatoblastoma susceptibility in Eastern Chinese children: A five-center case-control study

Huimin Yin, Xianqiang Wang, Shouhua Zhang, Shaohua He, Wenli Zhang, Hongting Lu, Yizhen Wang, Jing He, Chunlei Zhou

Review Article

Mechanisms of resistance to trastuzumab in HER2-positive gastric cancer

Zhifei Li, Huan Zhao, Huihui Hu, Haili Shang, Yongjing Ren, Wenhui Qiu, Hao Su, Huifang Lyu, Xiaobing Chen

Unlocking epigenetics for precision treatment of Ewing’s sarcoma

Zhehao Fan, Shuangshuang Dong, Ning Wang, Muhammad Babar Khawar, Jingcheng Wang, Haibo Sun

Brief Communication

Unraveling links between aging, circadian rhythm and cancer: Insights from evidence-based analysis

Dechao Feng, Yuhan Xiao, Jie Wang, Ruicheng Wu, Zhouting Tuo, Koo Han Yoo, Wuran Wei, Dilinaer Wusiman, Zhipeng Wang, Dengxiong Li, Yubo Yang, William C. Cho, Mang Ke